D.E. Shaw & Co
RPID icon

D.E. Shaw & Co’s Rapid Micro Biosystems RPID Stock Holding History

D.E. Shaw & Co’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,794
Closed -$121K – 5711
2022
Q1 		$121K Buy
+17,794
New +$131K ﹤0.01% 4972

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co's RPID Position: Q2 2022 in Review

D.E. Shaw & Co sold out of Rapid Micro Biosystems (RPID) in Q2 2022, closing a stake of 17,794 shares — an estimated $121K sold.

D.E. Shaw & Co first reported a position in RPID in Q1 2022 and held it in 1 quarter. The position peaked at $121K in Q1 2022. 52 funds tracked by Wall St. Rank hold RPID as of Q2 2022.

  • D.E. Shaw & Co reported no remaining Rapid Micro Biosystems position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 17,794 Rapid Micro Biosystems shares in Q2 2022, an estimated $121K.
  • D.E. Shaw & Co first reported a position in Rapid Micro Biosystems in Q1 2022 and held it in 1 quarter.
  • D.E. Shaw & Co's Rapid Micro Biosystems position peaked at $121K in Q1 2022.
  • 52 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.